Mutations in the autism-related Dyrk1a gene lead to brain undergrowth in mice. Researchers say an existing drug appears to reverse the damage.
Researchers have identified alterations in neural circuitry that impact cerebral cortex pathology. These alterations could be key to cognitive deficits in Down syndrome.
